China Vows Closer Oversight Of Heparin Producers

Law360, New York (March 21, 2008, 12:00 AM EDT) -- China's drug safety agency changed course Friday in response to the U.S. Food and Drug Administration's discovery that a dangerous contaminant in heparin could be traced to Chinese suppliers, saying that it would tighten controls on heparin production.

China's State Food and Drug Administration has reportedly posted a note on its Web site that heparin producers would be required to use only registered suppliers in an effort to prevent another round of contamination. The blood-thinning drug has been linked to 19 deaths and hundreds of allergic...
To view the full article, register now.